Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2177-2184
Published online before print August 25, 2005, doi: 10.1161/01.ATV.0000183613.13929.13
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/10/2177    most recent
01.ATV.0000183613.13929.13v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gauthier, A.
Right arrow Articles by McPherson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gauthier, A.
Right arrow Articles by McPherson, R.
Related Collections
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2177.)
© 2005 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Cholesteryl Ester Transfer Protein Directly Mediates Selective Uptake of High Density Lipoprotein Cholesteryl Esters by the Liver

Andre Gauthier; Paulina Lau; Xiaohui Zha; Ross Milne; Ruth McPherson

From Lipoprotein and Atherosclerosis Research Group & Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada.

Address correspondence to Ruth McPherson, University of Ottawa Heart Institute, H453, 40 Ruskin St, Ottawa, ON Canada K1Y 4W7. E-mail rmcpherson{at}ottawaheart.ca

Objective— To determine whether cholesteryl ester transfer protein (CETP) directly mediates selective uptake of high-density lipoprotein (HDL)-cholesteryl ester (CE) by hepatocytes and to quantify the effects of the CETP inhibitor, torcetrapib, on this process.

Methods and Results— Using adenovirus-mediated CETP (ad-CETP) expression in primary mouse hepatocytes from either wild-type, low-density lipoprotein (LDL) receptor–/– or SR-BI–/– mice, we demonstrate that CETP enhances the selective accumulation of HDL-derived 3H-CE independently of known lipoprotein receptors. Addition of torcetrapib to the media did not impair the ability of cell-associated CETP to enhance CE uptake but reduced the ability of exogenously added CETP to increase selective uptake by up to 80%. When mice were infected with ad-CETP or ad-Luciferase and treated with daily intravenous injections of torcetrapib or vehicle, hepatic CETP expression resulted in a 50% decrease in HDL cholesterol in vehicle-treated animals versus a 33% decrease in HDL cholesterol in mice treated with torcetrapib.

Conclusions— CETP mediates selective uptake of HDL-CE by hepatocytes by both torcetrapib-sensitive (exogenous CETP) and torcetrapib-insensitive (cell-associated CETP) mechanisms. Hepatic expression of CETP in vivo results in a marked decrease in cholesterol in particles in the HDL density range, consistent with a physiological role for hepatocyte CETP in selective uptake.

These studies demonstrate that cholesteryl ester transfer protein (CETP) mediates the selective uptake of IIDL-derived cholesteryl esters by hepatocytes both in vitro and in vivo by a mechanism that is independent of other lipoprotein receptors and which is only partially sensitive to inhibition by torcetrapib.


Key Words: CETP • selective uptake • torcetrapib • lipoproteins • HDL




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. Ahras, T. Naing, and R. McPherson
Scavenger receptor class B type I localizes to a late endosomal compartment
J. Lipid Res., July 1, 2008; 49(7): 1569 - 1576.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. Tchoua, W. D'Souza, N. Mukhamedova, D. Blum, E. Niesor, J. Mizrahi, C. Maugeais, and D. Sviridov
The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport
Cardiovasc Res, March 1, 2008; 77(4): 732 - 739.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Izem and R. E. Morton
Possible Role for Intracellular Cholesteryl Ester Transfer Protein in Adipocyte Lipid Metabolism and Storage
J. Biol. Chem., July 27, 2007; 282(30): 21856 - 21865.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. E. Borggreve, H. L. Hillege, G. M. Dallinga-Thie, P. E. de Jong, B. H.R. Wolffenbuttel, D. E. Grobbee, A. van Tol, R. P.F. Dullaart, and on behalf of the PREVEND Study Group
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides
Eur. Heart J., April 4, 2007; (2007) ehm062v1.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Harder, P. Lau, A. Meng, S. C. Whitman, and R. McPherson
Cholesteryl Ester Transfer Protein (CETP) Expression Protects Against Diet Induced Atherosclerosis in SR-BI Deficient Mice
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 858 - 864.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Gautier, U. J. F. Tietge, R. Boverhof, F. G. Perton, N. Le Guern, D. Masson, P. C. N. Rensen, L. M. Havekes, L. Lagrost, and F. Kuipers
Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein
J. Lipid Res., January 1, 2007; 48(1): 30 - 40.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Westerterp, C. C. van der Hoogt, W. de Haan, E. H. Offerman, G. M. Dallinga-Thie, J. W. Jukema, L. M. Havekes, and P. C.N. Rensen
Cholesteryl Ester Transfer Protein Decreases High-Density Lipoprotein and Severely Aggravates Atherosclerosis in APOE*3-Leiden Mice
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2552 - 2559.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Fazio and M. F. Linton
Sorting Out The Complexities of Reverse Cholesterol Transport: CETP Polymorphisms, HDL, and Coronary Disease.
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3273 - 3275.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. E. Borggreve, H. L. Hillege, B. H. R. Wolffenbuttel, P. E. de Jong, M. W. Zuurman, G. van der Steege, A. van Tol, R. P. F. Dullaart, and on behalf of the PREVEND Study Group
An Increased Coronary Risk Is Paradoxically Associated with Common Cholesteryl Ester Transfer Protein Gene Variations That Relate to Higher High-Density Lipoprotein Cholesterol: A Population-Based Study
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3382 - 3388.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. C.N. Rensen and L. M. Havekes
Cholesteryl Ester Transfer Protein Inhibition: Effect on Reverse Cholesterol Transport?
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 681 - 684.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven
Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis
Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 706 - 715.
[Abstract] [Full Text] [PDF]